Canada Pension Plan Investment Board acquired a portion of LifeArc’s royalty interests on worldwide sales of Keytruda®* (pembrolizumab) for US $1.297B Read More →
Blackstone Clarus, Omega Fund, and BVF backed ESSA Pharma to acquire BVF backed Realm Therapeutics in US $21.5M all-stock transactionRead More →
Milestone Pharmaceuticals priced US $82.5M IPO at US $15/share for US $355M valuation, US $235M of which owned by major backers led by RTW Investments, Novo Holdings, Fonds de solidarité, BDC CapitalRead More →
Biolux Research secured $14 million Series A from Venrock, Correlation Ventures, insiders and other investorsRead More →
LightIntegra Technology raised $5.9M in Series A funding from Genome BC, Boardwalk Ventures, Tower Beach Capital, Coleco Investments, and Quimby Investments (VCC)Read More →
Menlo Park, CA based Sofinnova Investments established Canadian office led by Dr. Maha Katabi and may commence Canadian fundraising for its upcoming XI fundRead More →
Sanderling Ventures invested in TAVEC Pharmaceuticals and moved the company from New York to Montreal. Sanderling funded Therillia Development will manage the investmentRead More →
Prometic Life Sciences to close recap with Thomvest’s Structured Alpha LP and Consonance Capital Management, with the investors gaining 80.68% and 15.87% post-recap stakesRead More →
FACIT Prospects Oncology Fund invested in Nanology Labs, a UofT spin-off biotech/pharmaceutical startup, awarded $50K to Xpan Inc.Read More →
Innovacorp backed ABK Biomedical raised $30M Series B funding co-led by F-Prime Capital and Varian Medical Systems (NYSE: VAR).
Read More →
Fusion Pharmaceuticals secured US $105M Series B from Varian, OrbiMed, Perceptive Advisors, Pivotal bioVenture Partners, Rock Springs Capital, Healthcap, Adams Street Partners, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), TPG Biotech, Seroba Life Sciences, Genesys Capital, FACIT.
Read More →
Sagard Healthcare Royalty Partners acquired stake in royalty interest in Rubraca, a novel cancer drug, from The University of Newcastle for US $31 million in cash.
Read More →
